Animal-assisted Trauma-focused Therapy for Children and Adolescents
Launched by UNIVERSITY OF BASEL · Oct 31, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how having an animal present during therapy can help children and teenagers who are struggling with the effects of trauma. The study involves 80 young participants, aged 9 to 17, who have experienced a traumatic event and show signs of post-traumatic stress. They will be divided into two groups: one will receive standard trauma-focused therapy, while the other will participate in animal-assisted therapy, where an animal is included in their therapy sessions. The goal is to see if having an animal helps these young people feel more motivated to attend therapy and successfully complete their treatment.
To be eligible for the study, participants need to be between 9 and 17 years old, have a history of trauma, and show post-traumatic stress symptoms. It's important that they have a positive or neutral attitude towards animals, as well as a basic understanding of German to participate in the sessions and fill out questionnaires. Parents or guardians will also be involved in three meetings to support their child’s therapy journey. This research could provide valuable insights into how animals can play a role in helping children and teens heal from trauma.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 9 and 17 years
- • experienced a traumatic event
- • remembers at least one traumatic event
- • Suffering from posttraumatic stress symptoms (screened via the CATS-2; cut-off ≥ 21; cut-off must be reached by either participant or caregiver)
- • Basic knowledge of child and parents in German to be able to understand content of the session and to fill in questionnaires
- • Informed consent (given by legal guardian for participants younger than 14 years)
- • Positive or neutral attitude towards animals
- Exclusion Criteria:
- • Inability to complete questionnaires due to lack of language skills or cognitive impairment
- • Diagnosed autism spectrum disorder; Exclusion only if interaction with others and group ability is limited due to autism
- • Reported significant impairment or safety issue (e.g., active suicidal ideation, acute psychosis)
- • Known abuse of substances used for emotion regulation (e.g. cannabis, alcohol, other hard drugs)
- • Fear of domestic animals
- • Allergic reactions to domestic animals
- • Reported aggressive behavior towards animals in the past
About University Of Basel
The University of Basel, established in 1460, is one of the oldest and most prestigious universities in Switzerland, renowned for its commitment to research and education in the life sciences, medicine, and clinical research. As a clinical trial sponsor, the university leverages its multidisciplinary expertise and state-of-the-art facilities to advance innovative therapeutic approaches and improve patient care. The University of Basel fosters collaboration among leading scientists, healthcare professionals, and industry partners, ensuring rigorous adherence to ethical standards and regulatory requirements in all clinical trials. Through its comprehensive research programs, the university aims to contribute significantly to the understanding and treatment of various medical conditions, ultimately enhancing global health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Zürich, , Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials